Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Condition: Other Skin Disorders Interventions: Biological: Autologous T Cells modified to recognize Merkel Cell Polyomavirus (FH-MCVA2TCR); Drug: Avelumab; Radiation: Radiation Therapy Sponsor: Fred Hutchinson Cancer Research Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials